May 21, 2020
Healthcare workers to participate in chloroquine study
Editor's Note
An international study will include more than 30,000 front-line healthcare workers to assess whether chloroquine can prevent COVID-19 or decrease its severity.
Washington University School of Medicine in St Louis is the clinical coordinating center for the study.
Healthcare workers will be divided randomly into four groups. Three groups will receive chloroquine at various doses, and the fourth group will receive a placebo.
The study will last 5 months.
Free Daily News
- AI is transforming nursing practice but demands stronger ethics, training
- Government shutdown stalls healthcare access, freezes Medicare telehealth, hospital-at-home services
- ACS launches hospital search tool to spotlight surgical quality
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
- FDA posts four device safety communications, prompting inventory, workflow checks
- 7 strategies healthcare leaders can use to turn around toxic workplace culture
- Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement